White label ELPA - ClinicalTrials.eu

Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+8
Study on Zanubrutinib for Patients with Primary Cold Agglutinin Disease

Not recruiting

2 1 1
Investigated diseases:
- Cold type haemolytic anaemia
Investigated drugs:
- Zanubrutinib
Study on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis

Not recruiting

2 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- Burfiralimab
Study of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Not recruiting

2 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Rezpegaldesleukin
+1
Study of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers

Not recruiting

1 1 1 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
Study on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Cervix carcinoma
Investigated drugs:
Study of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:
- Sodium Chloride
- Vrdn-001
+2
Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

Not recruiting

3 1 1 1
Investigated diseases:
- Colon cancer stage II
- Rectal cancer stage II
Investigated drugs:
- Capecitabine
Durvalumab Maintenance Therapy for Frail Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy

Not recruiting

2 1 1 1
Investigated diseases:
- Small cell lung cancer limited stage
Investigated drugs:
- Durvalumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies